11
Views
6
CrossRef citations to date
0
Altmetric
Original Article

A Review of the Reliability and Validity of the Drug Abuse Warning Network

&
Pages 57-77 | Published online: 03 Jul 2009

References

  • Anglin C. L., Santo Y., Harmatz J. S., Shader R. I. An Evaluation of Sedative Hypnotic Patients in DAWN Reporting Hospitals. Final Report by Macro Systems, Inc., for Services Research Branch, National Institute on Drug Abuse, Contract 271–77-4524. November 30, 1980
  • Barton Dawn W. A. An Operational Analysis and Evaluation. National Institute on Drug Abuse, Rockville, MD 1975
  • Chicago Tribune. The pill peddlers: Our No. 1 drug abuse dilemma. June 17–21, 1979
  • Franklin Research Center. DAWN Quality Assurance Study. Prepared for the Drug Enforcement Administration, Washington, DC, 1979
  • French J., Kaufman N. Prevention Evaluation Guidelines. National Institute on Drug Abuse. U.S. Government Printing Office, Washington, DC 1979
  • Greenberg S. W., Roberson C. B. Analysis of Drug Abuse Correlates. Final report by Research Triangle Institute for the Drug Enforcement Administration. 1978
  • Hinkley S. W. Statistician casts “clarifying light” on DAWN. The Journal (Toronto: Addiction Research Foundation). May, 1980
  • Ims America Ltd. DAWN Quarterly Report October-December, 1978. The Author, Ambler, PA 1978
  • Ims America Ltd. Project DAWN Annual Report 1979. The Author, Ambler, PA 1979
  • Kovar M. B., Wright R. An experiment with alternative respondent rules in the National Health Interview Survey. Proceedings of the American Statistical Association, Social Statistics Section, Washington, DC, 1973
  • Lasagna L. The DAWN's early light: A flickering flame. The Sciences. 1976
  • Mc Connell H. Data about worthless numbers. The Journal (Toronto: Addiction Research Foundation), p. 6. February 1, 1980
  • Murphy J. B. Chief, Information Systems Section, Drug Enforcement Administration. personal communication. January, 1981
  • Person P. H. The Drug Abuse Warning Network: A statistical perspective. Public Health Rep. 1976; 91: 395–401
  • Rhodes B. The New Hampshire Mini-DAWN: The nation's first statewide saturation drug abuse warning network: The data and its uses. Unpublished report, Governor's Office of Alcohol and Drug Abuse Prevention, State of New Hampshire. 1979
  • Rhodes B. Mini-DAWN: New Hampshire's experience. Paper presented at the National Alcohol and Drug Coalition Conference, Washington, DC., September 17. 1980
  • Rufener B., Rachal J., Cruze A. Management Effectiveness Measures for NIDA Drug Abuse Treatment Programs. Cost-Benefit Analysis (National Institute on Drug Abuse Technical Paper). U.S. Government Printing Office, Washington, DC 1976; Vol. 1
  • Rufener B., Rachal J., Cruze A. Management Effectiveness Measures for NIDA Drug Abuse Treatment Programs. Costs to Society of Drug Abuse (National Institute on Drug Abuse Technical Paper. U.S. Government Printing Office, Washington, DC 1977; Vol. 2
  • Ungerleider J. T., Lundberg G. D., Sunshine I., Walberg C. B. The Drug Abuse Warning Network (DAWN) program. Arch. Gen. Psychiatry 1980a
  • Ungerleider J. T., Lundberg G. D., Sunshine I., Walberg C. B. DAWN: Drug Abuse Warning Network or data about worthless numbers?. J. Anal. Toxicol. 1980b; 4, November-December
  • Ungerleider Lundberg. Sunshine, and Walberg. The Journal February, 1980c
  • U.S. Department of Justice. CSA Drug Activities Since October 27. Drug Enforcement Administration, Washington, DC 1978
  • White House. Seminar on Primary Prevention. Meeting held at the White House, December. 1977

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.